BCR and COVID-19: Given that severe COVID‐19 has been associated with the loss of germinal centers, CD4+ T cells and immunoglobulin M–positive (IgM+) B cells, it is possible that BCR maturation may be impaired in those with severe disease in comparison to those with mild disease,16, 17, 18, 19 negatively affecting long‐term humoral immunity.